{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T09:32:03Z","timestamp":1763458323226,"version":"3.37.3"},"reference-count":17,"publisher":"Endocrinology Research Centre","issue":"6","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.probl-endojournals.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":["www.probl-endojournals.ru"],"crossmark-restriction":true},"short-container-title":["Probl Endokrinol (Mosk)"],"abstract":"<jats:p><jats:bold>BACKGROUND<\/jats:bold>: 2025 is going to be the 100th anniversary of the first historical description of Turner syndrome \u2014 complex of \u00a0genomic abnormalities, congenital gonadal disruption and hypergonadotropic hypogonadism. Total estrogenic deficiency triggers development of age-related comorbidities. There is no doubt that personalized search for replicative markers of\u00a0cellular aging among females with Turner syndrome is needed.<\/jats:p><jats:p><jats:bold>AIM:<\/jats:bold> To evaluate features of replicative (telomere length) and biochemical (lipid profile, calcium-phosphate album, thyroid hormones, markers cytolysis and cholestasis, carbohydrate metabolism, nitrogenic metabolism, electrolytes, FSH) markers among females with Turner syndrome.<\/jats:p><jats:p><jats:bold>MATERIALS AND METHODS<\/jats:bold>. Research has been provided in collaboration between Endocrinology Research Centre of\u00a0the Russian Ministry of Health and Lomonosov Moscow State University Medical Research and Educational Centre in\u00a0the\u00a0period since 10.01.2021 until 01.08.2022. Females with non-iatrogenic hypergonadotropic hypogonadism caused by Turner syndrome (45,X0; 45,X\/46,XX; 45,X\/46,X,r(X); 13\u201340 y.o.; n=26) and primary ovarian insufficiency (18\u201339 \u043dyears=26); healthy females of\u00a0reproductive age (15\u201349 y.o.; n=24). Patients have undergone laboratory genetic (leucocyte telomere length), biochemical (fasting glycaemia, urea, creatinine, common\/conjugated bilirubin, ALT, AST, gamma-glutamyl transferase, triglycerides, HDL-P, LDL-P, common cholesterol, common\/ionized calcium, phosphate, vitamin D, sodium\/potassium\/chlorides, FSH, HbA1c) analyses. Body measurements \u2014 body mass, body height. DNA extraction \u2014 provided with Qiagen DNA blood mini kit (Germany). Leukocyte telomere length \u2014 with real-time polymerase chain reaction PCR (Flow-fish). Soft program IBM SPSS Statistics (version 26,0 for Windows).<\/jats:p><jats:p><jats:bold>RESULTS.<\/jats:bold> 1. Females with Turner syndrome have significantly lower mean telomere length (8,22 kB [6,63\u20139,30]) than with primary ovarian insufficiency (10, 34 \u043a\u0411 [8,41\u201313,08], p&lt;0,001) and healthy reproductive age females (10,77 kB [9,95\u201313,16], \u0440&gt;0,05).<\/jats:p><jats:p>2. Telomere length correlates directly and significantly with longevity of menopausal hormonal therapy among females with primary ovarian insufficiency (\u03c1 = 505; p&lt;0,001).<\/jats:p><jats:p>3. Patients with Turner syndrome are inclined to vitamin D deficiency (\u0440&lt;0,001), dyslipidemia (\u0440=0,01); increase of levels of aminotransferases, cholestasis markers, phosphate and FSH (\u0440&lt;0,001).<\/jats:p><jats:p><jats:bold>CONCLUSION.<\/jats:bold> Turner syndrome is serious genetic disease that leads not only to infertility but to significant decrease of\u00a0quality\/life longevity out of \u201chealthy aging\u201d conception.<\/jats:p>","DOI":"10.14341\/probl13256","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T18:16:18Z","timestamp":1706638578000},"page":"113-120","update-policy":"https:\/\/doi.org\/10.14341\/crossmarkpolicy2018","source":"Crossref","is-referenced-by-count":1,"title":["Replicative and biochemical ageing mechanisms among females with Turner syndromes"],"prefix":"10.14341","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5826-3186","authenticated-orcid":true,"given":"R. K.","family":"Mikheev","sequence":"first","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8425-0020","authenticated-orcid":true,"given":"E. N.","family":"Andreeva","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre; Moscow State University of Medicine and Dentistry of A.I. Evdokimov"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4979-7420","authenticated-orcid":true,"given":"O. R.","family":"Grigoryan","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7177-0254","authenticated-orcid":true,"given":"E. V.","family":"Sheremetyeva","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3396-8678","authenticated-orcid":true,"given":"M. S.","family":"Pankratova","sequence":"additional","affiliation":[{"name":"Endocrinology Research Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0274-1729","authenticated-orcid":true,"given":"E. V.","family":"Loginova","sequence":"additional","affiliation":[{"name":"People\u2019s Friendship University of Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5458","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"ref1","unstructured":"Dedov II, Peterkova VA, Volevodz NN. Sindrom Shereshevskogo\u2013Ternera (patogenez, klinika, diagnostika, lechenie). Metodicheskoe posobie dlia vrachei. Moscow; 2009. (In Russ.)."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Turner HH. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology. 1938;23(5):566-574. doi: https:\/\/doi.org\/10.1210\/endo-23-5-566","DOI":"10.1210\/endo-23-5-566"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ford CE, jones KW, Polani PE, et al. A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner\u2019s syndrome). Lancet. 1959;273(7075):711-713. doi: https:\/\/doi.org\/10.1016\/s0140-6736(59)91893-8","DOI":"10.1016\/S0140-6736(59)91893-8"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177(3):G1-G70. doi: https:\/\/doi.org\/10.1210\/endo-23-5-566.10.1530\/EJE-17-0430","DOI":"10.1530\/EJE-17-0430"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Keefe DL, Marquard K, Liu L. The telomere theory of reproductive senescence in women. Curr Opin Obstet Gynecol. 2006;18(3):280-285. doi: https:\/\/doi.org\/10.1210\/endo-23-5-566.10.1097\/01.gco.0000193019.05686.49","DOI":"10.1097\/01.gco.0000193019.05686.49"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Liu B, He Y, Wang Y, et al. Structure of active human telomerase with telomere shelterin protein TPP1. Nature. 2022;604(7906):578-583. doi: https:\/\/doi.org\/10.1038\/s41586-022-04582-8","DOI":"10.1038\/s41586-022-04582-8"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Roake CM, Artandi SE. Regulation of human telomerase in homeostasis and disease. Nat Rev Mol Cell Biol. 2020;21(7):384-397. doi: https:\/\/doi.org\/10.1038\/s41580-020-0234-z","DOI":"10.1038\/s41580-020-0234-z"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Turner KJ, Vasu V, Griffin DK. Telomere biology and human phenotype. Cells. 2019;8(1):73. doi: https:\/\/doi.org\/10.1210\/endo-23-5-566.10.3390\/cells8010073.","DOI":"10.3390\/cells8010073"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Gaydosh L, Mitchell C, Notterman D, et al. Demographic and developmental patterns in telomere length across adolescence. Biodemography Soc Biol. 2020;66(3-4):208-219. doi: https:\/\/doi.org\/10.1080\/19485565.2021.1983758","DOI":"10.1080\/19485565.2021.1983758"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Ishizuka B. Current understanding of the etiology, symptomatology, and treatment options in Premature Ovarian Insufficiency (POI). Front Endocrinol (Lausanne). 2021;12(3-4):208-219. doi: https:\/\/doi.org\/10.3389\/fendo.2021.626924","DOI":"10.3389\/fendo.2021.626924"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177(3):G1-G70. doi: https:\/\/doi.org\/10.1530\/EJE-17-0430","DOI":"10.1530\/EJE-17-0430"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Klein KO, Rosenfield RL, Santen RJ, et al. Estrogen replacement in turner syndrome: literature review and practical considerations. J Clin Endocrinol Metab. 2018;103(5):1790-1803. doi: https:\/\/doi.org\/10.1210\/jc.2017-02183","DOI":"10.1210\/jc.2017-02183"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Donadille B, Christin-Maitre S. Heart and Turner syndrome. Ann Endocrinol (Paris). 2021;82(3-4):135-140. doi: https:\/\/doi.org\/10.1016\/j.ando.2020.12.004","DOI":"10.1016\/j.ando.2020.12.004"},{"key":"ref14","unstructured":"Shankar Kikkeri N, Nagalli S. Turner Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Fuchs MM, Jost CHA, Said SM, et al. Cardiovascular surgery in Turner syndrome - early outcome and longterm follow-up. World J Cardiol. 2020;12(3):97-106. doi: https:\/\/doi.org\/10.4330\/wjc.v12.i3.97","DOI":"10.4330\/wjc.v12.i3.97"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Davis SM, Geffner ME. Cardiometabolic health in Turner syndrome. Am J Med Genet C Semin Med Genet. 2019;181(1):52-58. doi: https:\/\/doi.org\/10.1002\/ajmg.c.31678","DOI":"10.1002\/ajmg.c.31678"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Kveiborg M, Gravholt CH, Kassem M. Evidence of a normal mean telomere fragment length in patients with UllrichTurner syndrome. Eur J Hum Genet. 2001;9(11):877-879. doi: https:\/\/doi.org\/10.1038\/sj.ejhg.5200722","DOI":"10.1038\/sj.ejhg.5200722"}],"container-title":["Problems of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/viewFile\/13256\/10595","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T18:17:06Z","timestamp":1706638626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.probl-endojournals.ru\/jour\/article\/view\/13256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":17,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,1,25]]}},"URL":"https:\/\/doi.org\/10.14341\/probl13256","relation":{},"ISSN":["2308-1430","0375-9660"],"issn-type":[{"type":"electronic","value":"2308-1430"},{"type":"print","value":"0375-9660"}],"subject":[],"published":{"date-parts":[[2024,1,24]]}}}